Molecular and Functional Characterization of Myxobacteria Isolated from Soil in India
Total Page:16
File Type:pdf, Size:1020Kb
3 Biotech (2017) 7:112 DOI 10.1007/s13205-017-0722-9 ORIGINAL ARTICLE Molecular and functional characterization of myxobacteria isolated from soil in India 1 1 1 1,2 Shiv Kumar • Arun Kumar Yadav • Priyanka Chambel • Ramandeep Kaur Received: 6 December 2016 / Accepted: 6 April 2017 / Published online: 31 May 2017 Ó Springer-Verlag Berlin Heidelberg 2017 Abstract This study reports the isolation of myxobacteria Introduction from soil collected from plains in north India. Based on the morphology and 16S rDNA sequence, the isolated For decades, microbes have been the major contributor to myxobacteria were identified as Corallococcus sp., Pyxi- natural products for drug discovery and development. dicoccus sp., Myxococcus sp., Cystobacter sp. and Ar- The microbial natural products being used as drugs are: changium sp. The myxobacteria were functionally antibacterial agents, such as the penicillins, cephalos- characterized to assess their ability to produce antibacterial porins, aminoglycosides, tetracyclines and various and anticancer metabolites. The isolates were found to be polyketides; cholesterol lowering agents, such as mevas- functionally versatile as they produced extracellular tatin and lovastatin; immunosuppressive agents, such as bioactive molecules that exhibited high frequency of the cyclosporins and rapamycin; and anthelmintics and activities against Bacillus cereus, Mycobacterium smeg- antiparasitic drugs, such as the ivermectins (Buss and matis, Enterobacter cloacae and Pseudomonas syringae. Waigh 1995). The emergence of antibiotic-resistant The strains also showed cytotoxic activity against the pathogenic microorganisms and rapid development of human cancer cell lines of liver, pancreas, prostrate, bone resistance to chemotherapeutic drugs have necessitated and cervix. These results indicate the importance of iso- the discovery of structurally diverse and mechanistically lating diverse strains of myxobacteria from unexplored distinct antimicrobial and anticancer compounds. Most of habitats to find novel bioactive compounds. Moreover, the the microbial bioactive compounds discovered so far bioactive molecules explored in this study are predomi- originated from actinomycetes, but the focus is currently nantly hydrophilic compounds, obviating the limitations of on the less exploited microbes as viable sources of sec- solubility-related aspect of drug discovery. ondary metabolites; viz., marine bacteria, cyanobacteria, endosymbionts and myxobacteria. Myxobacteria are aer- Keywords Myxobacteria Á Functional characterization Á obic Gram-negative, unicellular, rod-shaped d-proteobac- Antibacterial Á Anticancer teria, distributed in a wide range of habitats including soil, bark of trees, decaying plant materials, and fresh- water and marine environment (Ravenschlag et al. 1999; Electronic supplementary material The online version of this Reichenbach 1999; Garcia et al. 2009; Dawid 2000). article (doi:10.1007/s13205-017-0722-9) contains supplementary material, which is available to authorized users. They have a very large genome size compared to other bacteria, and a number of structurally unique biologically & Ramandeep Kaur active secondary metabolites are produced by this group [email protected] of bacteria (Wenzel and Muller 2009; Han et al. 2013; Reichenbach 2001). Many compounds isolated from 1 Department of Biotechnology, Guru Nanak Dev University, Amritsar, Punjab 143005, India myxobacteria act on unique cellular targets, which, at the time of their discovery, were not targeted by other sec- 2 Department cum National Centre for Human Genome Studies and Research, Punjab University, Sector 14, Chandigarh, ondary metabolites (Bode and Muller 2006; Herrmann India et al. 2017). 123 112 Page 2 of 9 3 Biotech (2017) 7:112 Myxobacteria have been the source of several new to investigate myxobacteria to assess them as source of antibacterials, e.g., thuggacins from Sorangium cellulosum novel pharmaceutically active molecules. (active against Mycobacterium tuberculosis), crocacin Our study shows that myxobacteria isolated from soil in from Chondromyces crocatus (active against Gram-posi- India inhibit Bacillus cereus, Mycobacterium smegmatis tive bacteria), indiacens from Sandaracinus amylolyticus and Gram-negative bacteria (Pseudomonas syringae and (mildly inhibit Gram-positive and Gram-negative bacteria), Enterobacter cloacae) suggesting their potential to be disciformycins from Pyxidicoccus fallax (active against exploited as a source of antimicrobial compounds. The methicillin- and vancomycin-resistant Staphylococcus extracted molecules also showed antiproliferative activity aureus), Coralmycins (potent activity against Gram-nega- against the cancer cell lines of cervix, liver, pancreas, tive bacteria), etc. (Irschik et al. 2007; Kunze et al. 1994; prostate and bone. Most of the compounds tested in labo- Steinmetz et al. 2012; Surup et al. 2014; Kim et al. 2016). ratories fail to make it to the clinic because of bioavail- Several new antifungal compounds have also been reported ability limitations. To address this constraint, in this study, from myxobacteria: pedein A and B, miuraenamides, we focused on the assessment of bioactive potential of aurafurons A and B and cyrmenins (Kunze et al. water-soluble compounds secreted by myxobacteria. 2005, 2008; Iizuka et al. 2006; Sasse et al. 2003). A recent assessment of the antibacterial compounds form myxobacteria has revealed that most of these compounds Materials and methods are active against Gram-positive bacteria (Schaberle et al. 2014). All chemicals and media components were procured from Several secondary metabolites produced by myxobac- HiMedia, Sisco Research Laboratory, Lobachemie, Genei- teria are promising anticancer agents. Epothilone, a pacli- Merck or Sigma-Aldrich. All plastic wares and glass wares taxel mimetic, obtained from Sorangium cellulosum So were purchased from HiMedia, Tarsons or Borosil. ce56, has been approved for breast cancer treatment (Burris 2008). In 2007, ixabepilone, an analog of epothilone B, Isolation, purification and taxonomy was approved by FDA for the treatment of metastatic or of myxobacteria locally advanced taxane-resistant breast cancer (Tan and Toppmeyer 2008). Tubulysins, produced by Archangium Myxobacteria were isolated by baiting technique from the gephyra Ar 315, Angiococcus disciformis An d48 and soil samples collected near decaying plants and animals in Cystobacter sp. SBCb004, are potent growth inhibitors the plains of north India (Reichenbach and Hofle 1999). compared to taxol, epothilone and vincristine and are Escherichia coli and/or autoclaved baker’s yeast was effective in multidrug-resistant cell lines (Sasse et al. 2000; streaked on cycloheximide (100 lg/ml) incorporated water Steinmetz et al. 2004; Chai et al. 2010). Argyrin A and CleriGel plate as three parallel streaks, cross streak or dot. cruentaren A produced by Archangium gephyra and Cycloheximide (100 lg/ml)-treated soil samples were Byssovorax cruenta, respectively, are highly cytotoxic placed on E. coli/autoclaved yeast and incubated at 30 °C against various human tumor cell lines (Nickeleit et al. for 3–20 days. For purification, colony morphology and/or 2008; Kunze et al. 2007). Recently, nannocystin from fruiting bodies were viewed under stereomicroscope to Nannocystis sp. has been found to show activity against confirm the identity of myxobacteria according to the cri- various cancer cell lines by targeting eukaryotic translation teria indicated by Reichenbach and Dworkin (1992). The (Krastel et al. 2015). fruiting bodies and cells from the edge of the swarms were Although myxobacteria are an attractive source of new picked up and streaked on CY agar (g/l: Casitone, 10; yeast chemical class of compounds, they have not been fully extract, 1; CaCl2Á2H2O, 1; agar 20) or SP agar (DSZM exploited in the quest for new bioactive compounds, medium 222) and incubated at 30 °C. This step was because their isolation and purification are tedious. The repeated till the isolates were obtained in pure culture. fact that they are very sensitive to mechanical stress and Thereafter, the isolates were maintained on SP medium. are prone to lysis make their handling very difficult (Re- ichenbach and Dworkin 1992). The ability of myxobacteria Molecular characterization of myxobacteria to synthesize a particular compound is specific to a strain, which makes myxobacteria an attractive proposition for Genomic DNA isolation bioprospection (Reichenbach and Hofle 1999). In view of their immense potential as a source of natural compounds Myxobacteria were grown in SP medium at 30 °C for 48 h having new chemical structures with unique mechanism of on a rotary shaker. Genomic DNA was extracted using action and no report on functional diversity of myxobac- HiYieldTM Genomic DNA Mini Kit (Real Biotech Cor- teria from Indian habitats, the present study was undertaken poration, Taiwan). 123 3 Biotech (2017) 7:112 Page 3 of 9 112 PCR amplification of 16S rDNA extract (WE). The insoluble residual matter was dissolved in 250 ll DMSO and designated as DMSO extract (DE). Genomic DNA of myxobacterial isolates was used as To prepare extracts for checking the anticancer activity, template for PCR amplification of 16S rRNA gene with myxobacteria were grown in 300 ml of CY broth at 30 °C bacterial universal forward primer 8-27F (50-AGAGTT for 36 h in an incubator shaker. Thereafter, 300 ml of ethyl TGATCCTGGCTCAG-30) and reverse primer 1492R acetate was added to each flask and extraction was carried